Formulations of pimavanserin | Patent Number 11452721

US 11452721 B2
Application Number17693830
Publication NumberUS 20220193057 A1
Pendency6 months, 17 days
Filled DateMar 14, 2022
Priority DateAug 30, 2017
Publication DateJun 23, 2022
Expiration DateAug 29, 2037
Inventor/ApplicantsRavindra Tejwani
Emanuel Joseph Vizzotti
Stephen Edward Abele
ExaminesYOUNG, MICAH PAUL
Art Unit1618
Technology Center1600
Assignments
Acadia Pharmaceuticals Inc.
Current
Acadia Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.